RxDoctor Payments DataLook up a doctor →

Pamela Lorditch

Nurse Practitioner · Johnstown, PANPI 1437146651

Payments from drug & device makers

$81,233in general payments, 2019–2025

Across 1,167 payments — averaging $69.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$51K
  • Biohaven Pharmaceuticals, Inc.$13K
  • Teva Pharmaceuticals USA, Inc.$3K
  • Biohaven Pharmaceutical Holding Company Ltd.$3K
  • UCB, Inc.$805
  • Abbott$668
  • plus $9K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)239$50,817
Biohaven Pharmaceuticals, Inc.40$13,373
Teva Pharmaceuticals USA, Inc.334$3,426
Biohaven Pharmaceutical Holding Company Ltd.27$3,334
UCB, Inc.49$805
Abbott13$668
AstraZeneca(2 entities)30$590
Lundbeck LLC48$551
Neurocrine Biosciences, Inc.35$478
Biogen18$469
Eisai Inc.23$467
Argenx US, Inc.22$457
Sanofi24$394
Amgen(2 entities)28$381
E.r. Squibb & Sons, L.L.C.3$363
Amneal Pharmaceuticals LLC26$360
SK Life Science, Inc.13$333
Vanda Pharmaceuticals Inc.13$328
Bristol Myers Squibb17$259
Johnson & Johnson(2 entities)17$250
TG Therapeutics, Inc.10$245
EMD Serono, Inc.9$229
Kyowa Kirin, Inc.12$224
Pfizer11$211
Acadia Pharmaceuticals Inc12$209
Otsuka America Pharmaceutical, Inc.10$190
Livanova USA, Inc.3$182
Axsome Therapeutics, Inc.4$165
Banner Life Sciences, LLC8$116
MDD US Operations, LLC4$114
Impel Pharmaceuticals Inc.1$113
Sunovion Pharmaceuticals Inc.6$109
Genentech USA, Inc.5$98
Neurelis, Inc.6$84
Jazz Pharmaceuticals Inc.3$79
Lilly USA, LLC5$79
Merz Pharmaceuticals, LLC4$74
Collegium Pharmaceutical, Inc.4$70
Novartis3$65
Xeris Pharmaceuticals, Inc.2$46
Upsher-smith Laboratories LLC2$41
Tanabe Pharma America, Inc.2$38
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC2$33
Avion Pharmaceuticals2$29
Biodelivery Sciences International, Inc.2$29
Takeda Pharmaceuticals U.S.A., Inc.1$23
Life Molecular Imaging Ltd2$23
Bioventus LLC1$23
Electronic Waveform Lab, Inc.1$22
Novo Nordisk1$20
CSL Behring1$18
Virtus Pharmaceuticals LLC1$17
Amylyx Pharmaceuticals, Inc.1$17
Nevro Corp.1$16
GRT US Holding, Inc.1$15
GE HealthCare1$14
Ipsen Biopharmaceuticals, Inc1$13
Medtronic1$13
Cycle Pharmaceuticals Inc1$12
Arbor Pharmaceuticals, Inc.1$12

How this compares

$81,233 in reported general payments places this provider in the 95th percentile of 4,059 nurse practitioner providers in Pennsylvania.

See all nurse practitioner providers in Pennsylvania →

Medicare billing

Part B allowed, 2024
$20,891
Medicare patients
208
Services billed
310

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in Johnstown

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →